Clinical Trial Update: SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for SB-715992 in advanced or metastatic colorectal cancer (including colon and rectal cancers) were completed and results posted by the NC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• SB-715992

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-02